IS5691A - Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness - Google Patents

Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness

Info

Publication number
IS5691A
IS5691A IS5691A IS5691A IS5691A IS 5691 A IS5691 A IS 5691A IS 5691 A IS5691 A IS 5691A IS 5691 A IS5691 A IS 5691A IS 5691 A IS5691 A IS 5691A
Authority
IS
Iceland
Prior art keywords
treatment
ghs
serm
selective
growth hormone
Prior art date
Application number
IS5691A
Other languages
Icelandic (is)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.
Publication of IS5691A publication Critical patent/IS5691A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IS5691A 1998-06-16 2000-10-27 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness IS5691A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IS5691A true IS5691A (en) 2000-10-27

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5691A IS5691A (en) 1998-06-16 2000-10-27 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness

Country Status (30)

Country Link
EP (1) EP1087764A1 (en)
JP (1) JP2002518326A (en)
KR (1) KR20010052852A (en)
CN (1) CN1301160A (en)
AP (1) AP9901582A0 (en)
AR (1) AR018869A1 (en)
AU (1) AU4054799A (en)
BG (1) BG105041A (en)
BR (1) BR9911324A (en)
CA (1) CA2335134A1 (en)
CO (1) CO5070587A1 (en)
EA (1) EA200001186A1 (en)
GT (1) GT199900087A (en)
HN (1) HN1999000097A (en)
HR (1) HRP20000859A2 (en)
HU (1) HUP0102505A3 (en)
ID (1) ID27599A (en)
IL (1) IL138630A0 (en)
IS (1) IS5691A (en)
MA (1) MA26652A1 (en)
NO (1) NO20006312L (en)
OA (1) OA11505A (en)
PA (1) PA8475901A1 (en)
PE (1) PE20000646A1 (en)
PL (1) PL344981A1 (en)
SK (1) SK18912000A3 (en)
TN (1) TNSN99124A1 (en)
TR (1) TR200003544T2 (en)
WO (1) WO1999065486A1 (en)
ZA (1) ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2653300A (en) * 1999-02-08 2000-08-29 Mcgill University Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (en) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators
BR0113626A (en) * 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
PE20000646A1 (en) 2000-08-05
BG105041A (en) 2001-08-31
ZA993975B (en) 2000-12-15
JP2002518326A (en) 2002-06-25
TNSN99124A1 (en) 2005-11-10
KR20010052852A (en) 2001-06-25
OA11505A (en) 2004-05-07
PA8475901A1 (en) 2000-05-24
PL344981A1 (en) 2001-11-19
HUP0102505A2 (en) 2001-11-28
IL138630A0 (en) 2001-10-31
HRP20000859A2 (en) 2001-04-30
CN1301160A (en) 2001-06-27
CO5070587A1 (en) 2001-08-28
GT199900087A (en) 2000-12-07
WO1999065486A1 (en) 1999-12-23
NO20006312D0 (en) 2000-12-12
EA200001186A1 (en) 2001-06-25
HUP0102505A3 (en) 2002-12-28
ID27599A (en) 2001-04-12
AR018869A1 (en) 2001-12-12
SK18912000A3 (en) 2001-10-08
BR9911324A (en) 2001-04-03
HN1999000097A (en) 1999-11-03
CA2335134A1 (en) 1999-12-23
MA26652A1 (en) 2004-12-20
NO20006312L (en) 2000-12-12
EP1087764A1 (en) 2001-04-04
AU4054799A (en) 2000-01-05
AP9901582A0 (en) 1999-06-30
TR200003544T2 (en) 2001-04-20

Similar Documents

Publication Publication Date Title
IS5386A (en) Protein blend and process for isolating protein mixture from muscle tissue
GB2361878B (en) Bone cement mixer and method
DK0881354T3 (en) Method and apparatus for cementing a well
DK0946190T3 (en) Methods and Compositions for Stimulating Neurite Growth
AU6459000A (en) Method and apparatus for delivering cement to bones and/or positioning components
NO981426D0 (en) Method and apparatus for primary-well cementing
NO20020912D0 (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
DK1181397T3 (en) Rhodium electrocatalyst and process for its preparation
DK0808577T3 (en) Method and apparatus for making aerated frozen products
DK1021379T3 (en) Apparatus for purifying and draining water
NO20010468L (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
IS5691A (en) Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness
DK3497A (en) Sustained release formulation of an animal growth hormone and process for its preparation
DK0977736T3 (en) Process for the preparation of pure flupirtine maleate and its modification A
IS5719A (en) Treatment combinations consisting of selective estrogen receptor modulator and parathyroid hormone
DK1004583T3 (en) Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
DK0911303T4 (en) Method and system for controlling mixing of raw materials for cement
DK0957690T3 (en) Process for the preparation of feed for salmonids and feed for salmonids
DK0811324T3 (en) Method and apparatus for making frozen compositions containing pieces
IS5727A (en) Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness
NO20011824D0 (en) Controlled release fertilizer mixtures and processes for their preparation
GB9913560D0 (en) Mixing apparatus and method of mixing
DE69836870D1 (en) Interface adaptation circuit and method for its adjustment
DK0953291T3 (en) Method and machine for refining confectionery material
DK1031575T3 (en) Process for Preparation of Growth Hormone Secretion Inducers